Patents Examined by Clinton A Brooks
  • Patent number: 11145826
    Abstract: The present invention relates to a compound of an acridine derivate as well as of an organic semiconductor material an organic semiconductor layer, an electronic device comprising the acridine derivative, a device comprising an organic light-emitting diode comprising the acridine derivative, a display device thereof and a method of manufacturing the same. (I) wherein L is selected from phenylene, naphthylene and biphenylene; R1, R2, R3, R4 and R5 are independently selected from unsubstituted or substituted C6 to C18 aryl and unsubstituted or substituted pyridyl; and the substituents are selected from deuterium, C1 to C12 alkyl and C1 to C12 alkoxy; a, b, c, d and e are independently selected from 0 or 1 and 2?a+b+c+d+e?5.
    Type: Grant
    Filed: October 18, 2017
    Date of Patent: October 12, 2021
    Assignees: Novaled GmbH, Samsung SDI Co., Ltd.
    Inventors: Julien Frey, Domagoj Pavicic, Volodymyr Senkovskyy, Elena Galan, Hyungsun Kim, Byungku Kim
  • Patent number: 11130770
    Abstract: Disclosed a precursor compound for producing a photoactive layer of a thin film solar cell that may be used as a precursor of a CIS, CGS or CIGS thin film that may be used as a photoactive layer of a solar cell, and a production method thereof. The precursor compound is represented by a following Chemical Formula 1: wherein, in the Chemical Formula 1, X represents indium (In) or gallium (Ga), Y represents chlorine (Cl) or iodine (I), each of R1, R2, R3 and R4 independently represents a methyl group, a propyl group or an alkyl group having 2 to 10 carbon atoms.
    Type: Grant
    Filed: February 28, 2020
    Date of Patent: September 28, 2021
    Assignee: Research & Business Foundation Sungkyunkwan University
    Inventors: Duk Young Jung, Hyun Jong Lee, Ji Hyun Cha
  • Patent number: 11124533
    Abstract: Provided are an organometallic compound represented by Formula 1 and an organic light-emitting device including the same. The organic light-emitting device includes a first electrode; a second electrode facing the first electrode; an organic layer between the first electrode and the second electrode and including an emission layer; and at least one organometallic compound represented by Formula 1.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: September 21, 2021
    Assignee: Samsung Display Co., Ltd.
    Inventors: Mina Jeon, Soobyung Ko, Eunsoo Ahn, Hyunjung Lee, Sungbum Kim, Haejin Kim, Sujin Shin, Eunyoung Lee, Jaesung Lee, Junghoon Han
  • Patent number: 11123710
    Abstract: The present invention relates, in part, to an alpha-alumina support for a hydrogenation catalyst useful in hydrogenating fluoroolefins. In certain aspects, it relates to a method for hydrogenating a compound by contacting an olefin reactant having at least one carbon-fluorine bond, with a supported hydrogenation catalyst. The reaction results in a product that includes a hydrogenated derivative of the olefin. In certain embodiments, the supported hydrogenation catalyst includes a zero-valent metal disposed on an alpha-alumina support.
    Type: Grant
    Filed: April 4, 2013
    Date of Patent: September 21, 2021
    Inventors: Haiyou Wang, Hsueh S. Tung, Daniel C. Merkel
  • Patent number: 11124532
    Abstract: The invention comprises novel chiral metal complex compounds of the formula wherein M, PR2, R3 and R4 are outlined in the description, its stereoisomers, in the form as a neutral complex or a complex cation with a suitable counter ion. The chiral metal complex compounds can be used in asymmetric reactions, particularly in asymmetric reductions of ketones, imines or oximes.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: September 21, 2021
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Stephan Bachmann, Matthias Beller, Marcel Garbe, Kathrin Junge, Michelangelo Scalone
  • Patent number: 11117856
    Abstract: Disclosed herein are efflux pump inhibitors and pharmaceutical compositions comprising the same. The efflux pump inhibitors may be used in methods of preventing antibiotic resistance in a subject, and in methods of treating a bacterial infection in a subject. The efflux pump inhibitor may be co-administered with an antibiotic.
    Type: Grant
    Filed: April 29, 2019
    Date of Patent: September 14, 2021
    Inventors: Renee Fleeman, Radleigh G. Santos, Marcello Angelo Giulianotti, Lindsey Shaw
  • Patent number: 11114621
    Abstract: There is disclosed an electroactive composition including (a) a host compound having Formula I and (b) a photoactive dopant. In Formula I: R1 is the same or different at each occurrence and is D, alkyl, silyl, germyl, deuterated alkyl, deuterated silyl, or deuterated germyl; a is an integer from 0-7; b is an integer from 0-8; c is an integer from 0-4; and d is an integer from 0-7.
    Type: Grant
    Filed: June 26, 2017
    Date of Patent: September 7, 2021
    Inventors: Weiying Gao, Norman Herron
  • Patent number: 11111207
    Abstract: The present invention disclosed an improved one pot, one step process for halogenation of compound of formula (II) to afford corresponding halogenated compound of formula (I) having improved yield and increased selectivity under very mild conditions.
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: September 7, 2021
    Inventors: Shubhangi Bhalchandra Umbarkar, Atul Balasaheb Kulal, Amar Jaywant Deshmukh
  • Patent number: 11111261
    Abstract: The present invention relates to iron complex compounds for therapeutic use which are low in arsenic, chromium, lead, cadmium, mercury and/or aluminum, compositions thereof and processes for preparing said iron complex compounds.
    Type: Grant
    Filed: February 13, 2019
    Date of Patent: September 7, 2021
    Assignee: Pharmacosmos Holding A/S
    Inventors: Tobias S. Christensen, Hans B. Andreasen
  • Patent number: 11104629
    Abstract: Provided is a method for preparing a diol. In the method, a saccharide and hydrogen as raw materials are contacted with a catalyst in water to prepare the diol. The employed catalyst is a composite catalyst comprised of a main catalyst and a cocatalyst, wherein the main catalyst is a water-insoluble acid-resistant alloy; and the cocatalyst is a soluble tungstate and/or soluble tungsten compound. The method uses an acid-resistant, inexpensive and stable alloy needless of a support as a main catalyst, and can guarantee a high yield of the diol in the case where the production cost is relatively low.
    Type: Grant
    Filed: August 7, 2019
    Date of Patent: August 31, 2021
    Assignees: The Coca-Cola Company, Changchun Meihe Science and Technology Development Co., Ltd
    Inventors: Jing Liu, Hongbin Qi, Haiyu Ren, Indra Prakash, Yu Shi
  • Patent number: 11091493
    Abstract: The application is directed to efficient and economical processes as described in more detail below for the preparation of the beta 3 agonists of the formula of I-7 and intermediate compounds that can be used for making these agonists. The present disclosure relates to a process for making beta-3 agonists and intermediates using ketoreductase (KED) biocatalyst enzymes and methods of using the biocatalysts.
    Type: Grant
    Filed: June 26, 2020
    Date of Patent: August 17, 2021
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Feng Xu, Zhuqing Liu, Richard Desmond, Jeonghan Park, Alexei Kalinin, Birgit Kosjek, Hallena Strotman, Hongmei Li, Johannah Moncecchi
  • Patent number: 11084837
    Abstract: The present invention relates to a chemical deposition raw material for manufacturing an iridium thin film or an iridium compound thin film by a chemical deposition method, including an iridium complex in which cyclopropenyl or a derivative thereof and a carbonyl ligand are coordinated to iridium. The iridium complex that is applied in the present invention enables an iridium thin film to be manufactured even when a reducing gas such as hydrogen is applied. in which R1 to R3, which are substituents of the cyclopropenyl ligand, are each independently hydrogen, or a linear or branched alkyl group with a carbon number of 1 or more and 4 or less.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: August 10, 2021
    Inventors: Ryosuke Harada, Toshiyuki Shigetomi, Kazuharu Suzuki
  • Patent number: 11084787
    Abstract: The invention relates to a method of producing compound (I) by (A) reacting compound (II) formaldehyde and hydrogen in the presence of a metal catalyst, in a solvent, wherein the amount of the formaldehyde to be used is exceeding 1 mol and not exceeding 5 mol per 1 mol of compound (II), to obtain a mixture containing the formaldehyde and compound (I), and (B) mixing the obtained mixture containing the formaldehyde and compound (I) with hydrogen and a secondary amine selected from the group consisting of diethylamine, dipropylamine, diisopropylamine, butylethylamine, pyrrolidine, piperidine and morpholine, in the presence of a metal catalyst, in a solvent, and then removing the metal catalyst, followed by obtaining the compound (I) by distillation.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: August 10, 2021
    Inventors: Masahiro Takeda, Yohei Tanaka
  • Patent number: 11078219
    Abstract: [OBJECT] To provide a metal-organic framework having high hygroscopicity under low humidity conditions, and a method for producing such a metal-organic framework. [SOLVING MEANS] A method for producing a coordinatively unsaturated metal-organic framework includes the steps of providing a precursor metal-organic framework comprising a metal cluster and a polycarboxylic acid ion and a monocarboxylic acid ion coordinated to the metal cluster, and allowing the precursor metal-organic framework and a metal salt having a Lewis acidity to coexist in a solvent to desorb at least a part of the monocarboxylic acid ion, which is coordinated to the metal cluster, from the metal cluster, as well as a coordinatively unsaturated metal-organic framework, including an M6O8-x(OH)x-type metal cluster and carboxylic acid ions including a polycarboxylic acid ion as a polydentate ligand and a C1-3 monocarboxylic acid ion as a monodentate ligand coordinated to the metal cluster.
    Type: Grant
    Filed: June 10, 2019
    Date of Patent: August 3, 2021
    Inventor: Yoshio Ohashi
  • Patent number: 11066431
    Abstract: A complex has a structure of formula (1A): SnXn·(m)L, wherein X is at least one type of halogen atoms, L is a polar solvent molecule, n is a value from 1.5 to 2.5, and m is a value from 0.3 to 1.9. A perovskite compound has a structure of formula (2A): RSnXj, wherein Sn has an oxidation number from 1.5 to 2.5, R is at least one type of a monovalent cation, X is at least one type of halogen atoms, and j is a value from 2.5 to 3.5, and the perovskite compound is free of tin oxide; or a perovskite compound has a structure of formula (2B): R2M2BiX1, wherein R is at least one type of a monovalent cation, X is at least one type of halogen atoms; M2 is a monovalent metal, and i is a value from 5.0 to 7.0.
    Type: Grant
    Filed: January 26, 2018
    Date of Patent: July 20, 2021
    Inventors: Atsushi Wakamiya, Masashi Ozaki, Yasujiro Murata
  • Patent number: 11053421
    Abstract: A process is disclosed for making CF3CF?CHF. The process involves reacting CF3CClFCCl2F with H2 in a reaction zone in the presence of a catalyst to produce a product mixture comprising CF3CF?CHF. The catalyst has a catalytically effective amount of palladium supported on a support selected from the group consisting of alumina, fluorided alumina, aluminum fluoride and mixtures thereof and the mole ratio of H2 to CF3CClFCCl2F fed to the reaction zone is between about 1:1 and about 5:1. Also disclosed are azeotropic compositions of CF3CClFCCl2F and HF and azeotropic composition of CF3CHFCH2F and HF.
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: July 6, 2021
    Inventors: Velliyur Nott Mallikarjuna Rao, Mario Joseph Nappa, Allen Capron Sievert
  • Patent number: 11053263
    Abstract: A trichlorogermanide of formula (I): [R4N]/[R4P]Cl[GeCl3] (I), where R is Me, Et, iPr, nBu, or Ph, tris(trichlorosilyl)germanide of formula (II): [R4N]/[RrP][Ge(SiCl3)3] (II), where R is Me, Et, iPr, nBu, or Ph, a tris(trichlorosilyl)germanide adduct of GaCl3 of formula (III): [Ph4P][Ge(SiCl3)3*GaCl3], and a tris(trichlorosilyl)germanide adduct of BBr3 of formula (IV): [Ph4P][Ge(SiCl3)3*BBr3]. Also, methods for preparing the trichlorogermanides of formula (I), the tris(trichlorosilyl)germanide of formula (II), the tris(trichlorosilyl)germanide adduct of BBr3 of formula (IV).
    Type: Grant
    Filed: January 28, 2020
    Date of Patent: July 6, 2021
    Assignee: Evonik Operations GmbH
    Inventors: Julian Teichmann, Matthias Wagner, Hans-Wolfram Lerner
  • Patent number: 11052383
    Abstract: Disclosed herein is the use of manganese, iron, cobalt, or nickel complexes containing tridentate pyridine di-imine ligands as hydrosilylation catalysts. These complexes are effective for efficiently catalyzing hydrosilylation reactions, as well as offering improved selectivity and yield over existing catalyst systems.
    Type: Grant
    Filed: September 26, 2017
    Date of Patent: July 6, 2021
    Inventors: Keith James Weller, Crista Carmen H. Atienza, Julie Boyer, Paul Chirik, Johannes G. P. Delis, Kenrick Lewis, Susan A. Nye
  • Patent number: 11046718
    Abstract: Provided herein is a multifunctional particle and methods of forming the same. The multifunctional particle includes a surface of the particle; a first moiety coupled to the surface and having at least one substantially hydrophobic appendage; and a second moiety coupled to the surface and having at least one appendage comprising a reactive functional group and a substantially hydrophilic repeating unit, whereby the particle is substantially superhydrophobic as a result of the substantially hydrophobic appendage, chemically reactive as a result of the reactive functional group, and migratory to a surface of a substantially hydrophobic matrix in which the particle may be included as a result of the substantially hydrophilic repeating unit. Additionally, antimicrobial functional groups may be coupled to the surface.
    Type: Grant
    Filed: April 27, 2020
    Date of Patent: June 29, 2021
    Assignee: VELOX FLOW, LLC
    Inventor: Peter Craig Venema
  • Patent number: 11046638
    Abstract: The present invention provides processes for the preparation of zuclomiphene, as well as intermediates useful in the preparation thereof. In particular, processes are provided for the carbometallation of diphenylacetylene with a compound of Formula (3) to afford either zuclomiphene or an intermediate which is converted to zuclomiphene.
    Type: Grant
    Filed: November 11, 2020
    Date of Patent: June 29, 2021
    Assignee: Apotex Inc.
    Inventors: Avedis Karadeolian, Fabio E. S. Souza, Michael R. Emmett, Allan W. Rey